Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Aspargo Laboratories, Inc. See All Filings	D	2022-12-05 08:04:59 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Axiom Capital Management, Inc. and Newbridge Securities Corporation CIK Number 0001805092 Filed Document 0001753926-22-001525 Exclusions or Exemptions 506b Accepted Date 2022-12-05 08:04:59 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $$1 - $1,000,000 Type of Security Equity
Aspargo Laboratories, Inc. See All Filings	D	2022-03-28 15:19:21 UTC
Amount To Be Raised $60,000,000 Associated Brokers / Dealers Newbridge Securities Corporation CIK Number 0001805092 Filed Document 0001753926-22-000348 Exclusions or Exemptions 506b Accepted Date 2022-03-28 15:19:21 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity
Aspargo Laboratories, Inc. See All Filings	D/A	2020-10-15 09:38:24 UTC
Amount To Be Raised $8,500,000 Associated Brokers / Dealers Eagles Coast Capital and Arq Advisors CIK Number 0001805092 Filed Document 0001753926-20-000335 Exclusions or Exemptions 506b Accepted Date 2020-10-15 09:38:24 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity
Aspargo Laboratories, Inc. See All Filings	D/A	2020-07-28 08:11:58 UTC
Amount To Be Raised $8,500,000 Associated Brokers / Dealers David Sukoff CIK Number 0001805092 Filed Document 0001753926-20-000209 Exclusions or Exemptions 506b Accepted Date 2020-07-28 08:11:58 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity
Aspargo Laboratories, Inc. See All Filings	D	2020-03-03 09:52:22 UTC
Amount To Be Raised $8,500,000 Associated Brokers / Dealers N/A CIK Number 0001805092 Filed Document 0001753926-20-000030 Exclusions or Exemptions 506b Accepted Date 2020-03-03 09:52:22 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity